Di Yu

2.9k total citations
76 papers, 2.0k citations indexed

About

Di Yu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Di Yu has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Genetics and 20 papers in Oncology. Recurrent topics in Di Yu's work include Virus-based gene therapy research (22 papers), CAR-T cell therapy research (17 papers) and RNA Interference and Gene Delivery (10 papers). Di Yu is often cited by papers focused on Virus-based gene therapy research (22 papers), CAR-T cell therapy research (17 papers) and RNA Interference and Gene Delivery (10 papers). Di Yu collaborates with scholars based in Sweden, China and United States. Di Yu's co-authors include Yongqiang Qiu, Magnus Essand, Mohanraj Ramachandran, Chuan Jin, Chuan Jin, Miika Martikainen, Hai Wang, Anna Dimberg, Yue Yin and Jie Zhang and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Di Yu

69 papers receiving 1.9k citations

Peers

Di Yu
Kirsten Jensen United Kingdom
Tamara A. Kucaba United States
Jia Zhang China
Philip M. Sass United States
Mark G. Goebl United States
Simon J. McGowan United Kingdom
Kirsten Jensen United Kingdom
Di Yu
Citations per year, relative to Di Yu Di Yu (= 1×) peers Kirsten Jensen

Countries citing papers authored by Di Yu

Since Specialization
Citations

This map shows the geographic impact of Di Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Yu more than expected).

Fields of papers citing papers by Di Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Yu. The network helps show where Di Yu may publish in the future.

Co-authorship network of co-authors of Di Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Di Yu. A scholar is included among the top collaborators of Di Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Yu. Di Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Di, et al.. (2025). Enhanced spatial shifts of reflected beam on natural hyperbolic materials by polariton conversions. Chinese Journal of Physics. 95. 827–839.
2.
Zhang, Xian, Xiaoyu Li, Zheng Y. X. Huang, et al.. (2025). Prevalence of Avian Influenza Viruses and Biomolecular Analysis of H9N2 Subtype in Live Poultry Markets from 2021 to 2023 in Changsha, China. Food and Environmental Virology. 17(3). 38–38.
3.
Aramesh, Morteza, Di Yu, Magnus Essand, & Cecilia Persson. (2024). Enhanced Cellular Uptake through Nanotopography‐Induced Macropinocytosis. Advanced Functional Materials. 34(28). 3 indexed citations
4.
Martikainen, Miika, Roberta Lugano, Ilkka Pietilä, et al.. (2024). VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier. Nature Communications. 15(1). 10718–10718. 5 indexed citations
5.
Zhang, Rusheng, Huiyuan Fu, Zheng Y. X. Huang, et al.. (2024). Chlamydia psittaci detected at a live poultry wholesale market in central China. BMC Infectious Diseases. 24(1). 585–585. 3 indexed citations
6.
Yu, Yong, et al.. (2023). Targeting acetyl-CoA carboxylase 1 for cancer therapy. Frontiers in Pharmacology. 14. 1129010–1129010. 32 indexed citations
7.
Ali, Arwa, Menghan Gao, Hai Wang, et al.. (2023). Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment. Frontiers in Immunology. 14. 1146413–1146413. 2 indexed citations
8.
Yu, Di, et al.. (2022). A qPCR-Based Method for Quantification of Replication Competent Adenovirus (RCA) in Conditionally Replicating Oncolytic Adenoviruses. Methods in molecular biology. 2521. 249–258. 2 indexed citations
9.
Yin, Yue, Wen Su, Jie Zhang, et al.. (2021). Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19. ACS Nano. 15(9). 14347–14359. 100 indexed citations
10.
Yin, Yue, Xiaoyang Li, Haixia Ma, et al.. (2021). In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy. Nano Letters. 21(5). 2224–2231. 160 indexed citations
11.
Martikainen, Miika, Mohanraj Ramachandran, Roberta Lugano, et al.. (2021). IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma. Molecular Therapy — Oncolytics. 21. 37–46. 18 indexed citations
13.
Pellegrini, Paola, Thomas Lundbäck, Magdalena Mazurkiewicz, et al.. (2018). A drug screening assay on cancer cells chronically adapted to acidosis. Cancer Cell International. 18(1). 147–147. 19 indexed citations
14.
Kundu, Soumi, Di Yu, Tommie Olofsson, et al.. (2017). Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth. Molecular Cancer Therapeutics. 16(8). 1705–1716. 30 indexed citations
15.
Essand, Magnus, et al.. (2017). CAR T-Cells with Induced Secretion of Helicobacter Pylori Neutrophil-Activating Protein (HP-NAP) Yields Improved Anti-Tumor Activity and Reduced Immunosuppression. Molecular Therapy. 25. 288–288. 1 indexed citations
16.
Ramachandran, Mohanraj, et al.. (2017). Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity. Molecular Therapy — Oncolytics. 7. 67–75. 7 indexed citations
17.
Sun, Yongge, Zhisong Cui, Di Yu, et al.. (2017). Periodically spilled-oil input as a trigger to stimulate the development of hydrocarbon-degrading consortia in a beach ecosystem. Scientific Reports. 7(1). 12446–12446. 9 indexed citations
18.
Ramachandran, Mohanraj, Di Yu, Matheus Dyczynski, et al.. (2016). Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus. Clinical Cancer Research. 23(6). 1519–1530. 44 indexed citations
19.
Jin, Chuan, et al.. (2014). Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors. Molecular Therapy — Methods & Clinical Development. 1. 14001–14001. 27 indexed citations
20.
Ding, Lin, et al.. (2009). Preparation of monoclonal antibody against Shiga-like toxin type II variant B.. Zhongguo yufang shouyi xuebao. 31(3). 222–240. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026